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Abstract
Generalized anxiety disorder (GAD) and unipolar depressive disorders (UDD) have been shown to 
differ from each other in dimensions of affective functioning despite their high rates of 
comorbidity. We showed emotional film clips to a community sample (n = 170) with GAD, GAD 
with secondary UDD, or no diagnosis. Groups had comparable subjective responses to the clips, 
but the GAD group had significantly lower heart rate variability (HRV) during fear and after 
sadness, compared to controls. While HRV in the GAD and control groups rose in response to the 
sadness and happiness clips, it returned to baseline levels afterwards in the GAD group, potentially 
indicating lesser ability to sustain attention on emotional stimuli. HRV in the GAD + UDD group 
changed only in response to sadness, but was otherwise unvarying between timepoints. Though 
preliminary, these findings suggest comorbid UDD as a potential moderator of emotional 
responding in GAD.
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Compliance with Ethical Standards
Conflict of Interest Saren H. Seeley, Douglas S. Mennin, Amelia Aldao, Katie A. McLaughlin, Jonathan Rottenberg, and David M. 
Fresco declare that they have no conflict of interest.
Ethical Approval All procedures performed in studies involving human participants were in accordance with the ethical standards of 
the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable 
ethical standards.
Informed Consent Informed consent was obtained from all individual participants included in the study.
Animal Rights No animal studies were carried out by the authors for this article.
HHS Public Access
Author manuscript
Cognit Ther Res. Author manuscript; available in PMC 2016 September 20.
Published in final edited form as:
Cognit Ther Res. 2016 June ; 40(30): 290–303. doi:10.1007/s10608-015-9744-y.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
Generalized anxiety disorder; Heart rate variability; Emotion; Comorbidity
Introduction
Generalized anxiety disorder (GAD) is highly comorbid with unipolar depressive disorders 
(UDD) including major depressive disorder and dysthymia (Hoffman et al. 2008; Kessler et 
al. 2005). Efforts to differentiate transdiagnostic from disorder-specific features of GAD and 
UDD continue to represent a challenge for both research and clinical efforts; perhaps 
consequently, these disorders tend to be most disabling and refractory to treatment when 
they co-occur (Barrera and Norton 2009; Garcia et al. 2015; Mennin and Fresco 2013; 
Zimmerman and Chelminski 2003). Given considerable genotypic and phenotypic overlap in 
addition to lifetime and concurrent comorbidity, some scholars suggest that GAD and UDD 
are better subsumed under a broader category of ‘distress disorders’ within a hierarchical 
structure of arousal and positive and negative affect (e.g., Brown et al. 2001; Gorwood 2004; 
Watson 2005). A counterpoint to these structural models comes from the difficulty they have 
in accounting for contextual factors, or functional relationships in affective functioning (e.g., 
Brown and Barlow 2005; see Mennin et al. 2008). In order to discriminate disorder-specific 
phenomena from transdiagnostic markers of psychopathology, it will be important to clarify 
the nature of response heterogeneity, or differences in response to emotion, as a function of 
comorbidity. In this study, we examined physiological response to emotion-eliciting film 
clips in a large community sample of adults with GAD or GAD with secondary UDD, and 
non-diagnosed controls.
Emotions provide us with a sense of our goals and needs and facilitate our ability to make 
decisions and navigate our environment (e.g., Frijda 1986). Yet, intensely-felt emotions can 
also become highly distressing and disabling (Gratz and Roemer 2004; Gross and Jazaieri 
2014). The arousal associated with normal emotional experiences, even positive experiences, 
can feel unpleasant or even threatening, and thus become translated as anxiety to individuals 
with GAD (e.g., Llera and Newman 2014; Mennin et al. 2007). Worry functions as an 
attempt to dampen this arousal, or to attenuate aversive shifts between contrasting emotional 
states—for example, joy and disappointment (e.g., Borkovec et al. 2004; Llera and Newman 
2014). Much distress in UDD as well as in GAD stems from internally-mediated attempts to 
manage emotions (e.g., Borkovec et al. 2004; Fresco et al. 2002; Kertz et al. 2012; Mennin 
and Fresco 2013; Nolen-Hoeksema et al. 2008). However, UDD is marked by dampened 
intensity and reactivity, in contrast to the typically heightened emotionality associated with 
GAD (e.g., Mennin and Fresco 2015; Rottenberg et al. 2005a).
One mechanism through which heightened intensity might give rise to later blunted 
emotional responding is the prolonged suppression of autonomic arousal associated with 
chronic worry (e.g., Borkovec et al. 2004). Autonomic nervous system (ANS) activity is a 
central part of how we experience emotions (Bradley and Lang 2000; Gross 1998; Kreibig 
2010). Heart rate variability (subtle beat-to-beat changes in heart rate) results from 
fluctuating ANS influence on cardiac function (see Shaffer et al. 2014). HRV is thought to 
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reflect the functional integrity of a central autonomic network that plays an integral role in 
facilitating communication between brainstem and forebrain structures (e.g., hypothalamus, 
amygdala, medial prefrontal cortex) and visceral organs, including the heart, in service of 
self-regulation (see Thayer et al. 2012). Typically, non-anxious individuals demonstrate 
rapid physiological adaptation to stressors, reacting strongly to threats, but then returning 
quickly to baseline once the threat is past. However, chronically anxious individuals show 
weaker responses and delayed recovery (e.g., Hoehn-Saric and McLeod 2000; Lyonfields et 
al. 1995). HRV is a well-suited measure of this type of flexible (or inflexible) responding, as 
an index of the ability to dynamically adjust to physical, cognitive and emotional challenges 
in the environment (e.g., Appelhans and Luecken 2006; Geisler et al. 2010; Porges 2007; 
Thayer and Lane 2000). Decreased HRV is associated with inhibitory deficits common to 
GAD such as threat bias, perseveration, and prolonged physiological arousal (Friedman 
2007; Thayer and Lane 2009). Lower HRV in GAD may indicate a defensive and 
disorganized response style in which physiological rigidity mirrors an inflexible cognitive 
and behavioral repertoire that is typified by worry and avoidance (e.g., Aldao and Mennin 
2012; Movius and Allen 2005; Thayer et al. 1996).
Numerous studies support an association between anxiety disorders and decreased HRV 
(Chalmers et al. 2014). However, not all studies have shown significantly different resting 
state, or tonic, HRV in individuals with GAD relative to controls (e.g., Aldao and Mennin 
2012; see Chalmers et al. 2014). Importantly, the extant literature suggests that there may be 
moderators of the reduced HRV in GAD. One such factor is likely to be the presence of 
comorbid UDDs. Decreased parasympathetic activity may underlie the higher rates of 
cardiovascular disease observed in major depressive disorder (MDD; e.g., Nahshoni et al. 
2004; Udupa et al. 2007; van der Kooy et al. 2006). However, lower tonic HRV may not 
represent a stable and robust marker of depression (c.f. Brunoni et al. 2013); for example, 
the meta-analysis by Rottenberg (2007) found that MDD diagnosis explained just 2 % of 
overall variance in tonic HRV. Decreased tonic HRV may also be secondary to 
anticholinergic properties of some antidepressants (e.g., Kemp et al. 2014a; Licht et al. 
2008), or attendant symptoms of depression such as low mood or poor sleep (Bylsma et al. 
2014; Salomon et al. 2013). By contrast, there is more consistent support for dysregulated 
HRV in at the phasic level in MDD, evidenced by decreased physiological reactivity to 
emotional stimuli (e.g., Rottenberg et al. 2005a; Rottenberg et al. 2007; Salomon et al. 2009; 
Yaroslavsky et al. 2013). This dampened reactivity reflects a larger pattern of ‘emotional 
context insensitivity’ which may represent an endophenotype for depression (Bylsma et al. 
2008; Yaroslavsky et al. 2014).
Few studies have explored how HRV responses to emotion in GAD might vary as a function 
of comorbid depression. Kemp and colleagues (2012) found decreased HRV in patients with 
MDD, compared to individuals with no psychiatric diagnosis; further, the comorbid MDD + 
GAD group exhibited the lowest HRV relative to MDD-only and control groups. Likewise, 
in a sample of Taiwanese patients, individuals with GAD and comorbid MDD showed the 
lowest levels of HRV relative to individuals with GAD alone, though HRV was reduced in 
both groups relative to controls (Chang et al. 2013). However, both studies focused solely on 
tonic HRV. In contrast to the above studies, Hofmann and colleagues (2010) found that GAD 
individuals without comorbid MDD displayed consistently lower HRV than those with 
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comorbid depression throughout experimentally-induced worry and relaxation as well as at 
baseline. Examining HRV on a phasic level (i.e., in the context of emotional responding) 
may therefore provide additional insight into the role of emotional experience in GAD 
psychopathology. Indeed, Llera and Newman (2010) found that worry increased general 
negative affect in individuals with GAD, yet decreased both physiological and/or subjective 
reactivity to fear and sadness stimuli. Although the greater cognitive load associated with 
chronic worry alone has been suggested to underlie the relationship between GAD and 
decreased HRV, other studies have demonstrated reduced HRV in emotional contexts 
independent of worry (e.g., Pieper et al. 2007; Verkuil et al. 2009), and it will be important 
to clarify whether dysregulated physiological activity in emotional contexts represents a 
transdiagnostic or disorder-specific feature of GAD and comorbid depression.
It is also notable that no study to date has yet specifically examined the impact of comorbid 
UDD (either dysthymia or major depressive disorder) on HRV in GAD. While there have 
been few HRV studies specifically contrasting dysthymia to MDD, there is some evidence 
that there may not be meaningful differences between these diagnostic categories. For 
example, Harte et al. (2013) found no differences in HRV between participants in their 
sample with dysthymia versus those with MDD, and suggest that the specific diagnosis may 
not have an effect on HRV above and beyond simply meeting the diagnostic threshold for a 
depressive disorder. Given that MDD and dysthymia have similar rates of comorbidity with 
GAD (e.g., Watson 2005), a sample featuring GAD individuals with comorbid UDD, rather 
than MDD alone, should increase ecological validity of any observed effects.
In the current study, we presented film clips used widely in previous studies of emotion and 
HRV (e.g., Rottenberg et al. 2007) to a community sample of adults in three groups: a) 
individuals with GAD alone, b) individuals with primary GAD with secondary UDD (GAD 
+ UDD), and c) healthy controls. We recorded subjective and physiological responses to 
emotional (fear, sad, happy) film clips, as well as at baseline and during a brief recovery 
period. We predicted that individuals with GAD and GAD + UDD would show distinct 
patterns of physiological response to emotion that differed from controls and from each 
other. We expected that GAD + UDD and non-comorbid GAD groups would exhibit 
different patterns of HRV responses to the film clips such that individuals with GAD alone 
would show more phasic activity across the experiment as a function of heightened 
emotional intensity, whereas those with GAD + UDD would show a less differentiated 
pattern of HRV response to emotional contexts. This was based on earlier similar 
investigations (e.g., Aldao et al. 2013; Hofmann et al. 2010; Llera and Newman 2010), as 
well as evidence from prior studies suggesting that comorbid depression may moderate 
heightened emotional reactivity in GAD and other anxiety disorders (e.g., Taylor-Clift et al. 
2011; Weinberg et al. 2012). Finally, we expected to see that self-reported emotion across 
the experiment would differ between GAD-only and comorbid GAD + UDD groups in one 
of two directions: 1) that the GAD + UDD group would demonstrate blunted subjective 
emotion reactivity (i.e., lower affect ratings) across emotional contexts, or 2) that negative 
affect ratings would be elevated in the GAD + UDD group as a function of greater severity.
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Method
Participants
As part of two larger studies of emotion in affective disorders, individuals with and without 
GAD and depressive disorders were recruited from the greater New Haven, CT (n = 138) 
and Kent, OH communities (n = 38) surrounding Yale and Kent State Universities through 
flyers placed in local papers, on campus, and online through Craigslist (http://craigslist.org). 
Criteria for inclusion in the present sample were a primary DSM-IV diagnosis (American 
Psychological Association 2013) of either GAD (n = 58) or primary GAD with secondary 
unipolar depressive disorder (GAD + UDD; MDD n = 22, dysthymia n = 14). Controls (n = 
76) met no criteria for any diagnosis. Individuals with a primary diagnosis of any other 
Axis-I disorder— including psychotic, adjustment, substance, or bipolar disorders—were 
ineligible to participate. Also ineligible were participants with a systemic medical condition 
(e.g., heart disease, epilepsy), or who were currently taking medications known to directly 
affect cardiac function (e.g., beta blockers). The majority of the sample as a whole identified 
as female (64.8 %) and White (63.6 %), with a mean age of 28.00 (SD = 8.89). Sample 
characteristics in each of the three groups, including secondary diagnoses and other 
medication use, are described in Table 1. The two sites did not significantly differ in terms of 
gender, F(2,155) = .168, p = .867, but Yale participants (Mage = 30.04, SD = 8.75) on the 
whole were older than Kent State participants (Mage = 19.70, SD = 1.84), t(149.74) = 
−12.01, p < .001, given that Yale imposed an additional criterion that excluded current 
undergraduates.
Procedures
Diagnostic Assessment—Prospective participants were scheduled for a diagnostic 
interview (Structured Clinical Interview for the DSM-IV—Research Version [SCID-IV-RV]; 
First et al. 2002) conducted by advanced clinical psychology graduate students who had 
completed a rigorous six-month training on diagnostic assessment using the SCID-IV-RV. 
Interviewers had to achieve reliability in their diagnoses with experienced diagnosticians 
before conducting assessments independently. A proportion of the interviews were video-
recorded for training and supervision purposes, and an additional rater (AA) watched a 
subset (25 %) of these recordings in order to code for each diagnosis of GAD and depressive 
disorders, κ’s from .89 to 1; for other disorders, κ’s from .70 to .85). One departure from the 
SCID procedures was that the assessment protocol for the present study disregarded the 
hierarchy rule (i.e., GAD that only co-occurs with UDD is an epiphenomenon of depression, 
rather than a separate diagnosis), given evidence to suggest that there are few if any 
meaningful differences between individuals with a DSM-IV GAD diagnosis and those who 
would otherwise meet the diagnostic threshold for GAD except for the hierarchy rule (e.g., 
see Zimmerman and Chelminski 2003).
Experimental Session—Several days after the diagnostic interview, participants returned 
for the experimental session during which they completed self-report measures and the 
emotional videos task. After a research assistant set up the psychophysiological equipment, 
participants sat quietly for a 5-min resting baseline recording. They then viewed the fear, 
happy and sad film clips in counterbalanced order. After each of the film clips, participants 
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provided state emotion ratings. A physiological recovery period also followed each film, 
during which participants remained seated while resting for 2 min. The experimental session 
also involved completing several other computerized tasks not described here, which were 
counterbalanced with the film clips task. Procedures for the diagnostic interview and 
emotional videos task were identical at the two sites. All participants provided informed 
consent, and were compensated 30 dollars for their time. The study was approved by the 
Institutional Review Boards of Yale University and Kent State University.
Emotion Elicitation—Participants viewed film clips from the movies Silence of the 
Lambs (fear), Frequency (happiness), and Return to Me (sadness) that have been widely 
used for emotion induction in previous investigations of anxiety and depression (e.g., Aldao 
and Mennin 2012; Llera and Newman 2010; Rottenberg et al. 2007). Stimuli were presented 
with Superlab 4.0.7 (Superlab, Cedrus, Inc. San Pedro, CA, USA) on a desktop computer.
Psychophysiological Set Up—The electrocardiogram (EKG) was recorded using two 
disposable pre-gelled 11-mm Ag/AgCl electrodes (EL503; Biopac Systems, Inc., Goleta, 
California, USA), connected to an ECG100C amplifier for the MP150 System (Biopac 
Systems, Inc.). Respiration and electrodermal activity (not described here) were recorded 
simultaneously via their respective transducers. A research assistant helped participants to 
secure the strain gauge respiration belt around their chest and place the electrodes for the 
EKG in a modified lead-II configuration on their right shoulder and left hip. The EKG was 
acquired continuously in AcqKnowledge 3.9 (Biopac Systems, Inc.) and digitized at a 
sampling rate of 1 kHz with high- and low-pass filters at .5 and 35 Hz.
Heart Rate Variability—EKG data in each segment (baseline, emotion film clips, 
recovery periods) were exported as a series of interbeat intervals (IBIs) in milliseconds from 
AcqKnowledge for cleaning and processing using QRSTool and CMetX software (Allen et 
al. 2007; http://psychofizz.org). Both programs have shown good field validity (Hibbert et al. 
2012). QRSTool interpolates the IBI series in a graphical user interface for semi-automatic 
R-peak detection, followed by visual inspection and manual correction of any missed beats. 
CMetX calculates various time-domain metrics of HRV from the cleaned data, including the 
mean square difference of successive IBIs (MSD), which has previously shown ability to 
distinguish GAD from non-GAD participants (e.g., Thayer et al. 1996; Aldao and Mennin 
2012; Aldao et al. 2013; Mankus et al. 2013). Data segments containing excessive artifacts 
due to movement or interference were excluded from analysis (Berntson and Stowell 1998). 
To further reduce the likelihood of artifact contamination, we standardized the resulting 
HRV values as Z-scores in SPSS 20.0 (IBM Corp, Armonk, NY) and values more than three 
standard deviations from the mean were removed, checked against the CMetX output that 
indicates whether any additional artifacts were identified in the cleaned data. MSD values 
were positively skewed (skewness statistic [ 2), so we performed a logarithmic 
transformation on MSD in each segment, which reduced skewness statistics to 1 or lower. 
Subsequently, ‘HRV’ refers to the log10-transformed MSD.
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Self-Report Measures
Baseline Measures—In line with previous studies (e.g., Hofmann et al. 2010) we 
administered self-report questionnaires to assess levels of the defining clinical features of 
our diagnoses (i.e., worry in GAD; depressive symptoms in UDD).
Beck Depression Inventory-II (BDI-II)—The BDI-II (Beck et al. 1996) is a widely-used 
measure of depressive symptom (e.g., anhedonia, irritability, sleep disturbance, tearfulness, 
excessive guilt) presence and severity within the previous 2 weeks. BDI scores in the present 
sample showed high internal consistency (Cronbach’s α = .93).
Penn State Worry Questionnaire (PSWQ)—The PSWQ (Meyer et al. 1990) assesses 
the degree to which one’s worry is pervasive, uncontrollable, and excessive, and is 
considered a ‘gold standard’ measure of GAD-relevant worry. Cronbach’s α = .95 in the 
present sample.
Worry and Rumination Visual Analog Scales (WVAS and RVAS)—In order to 
examine whether any observed differences between comorbid and non-comorbid GAD 
groups might be a result of differences in worry or rumination at the time of the experiment, 
we also asked participants to rate their present level of each at baseline. Participants were 
provided with operational definitions of worry and rumination and asked to construct two 
visual-analogue scales using idiographic anchors. They provided five scenarios from their 
own lives associated with different levels of worry or rumination, from zero (‘none’) to 100 
(‘extreme’), then used these as a frame of reference to rate their level of worry and 
rumination at that moment. This type of idiographic VAS has previously been used to 
measure worry at the state level (e.g., McLaughlin et al. 2007; Aldao et al. 2013).
Subjective Emotion Ratings—At baseline and after each of the four film clips, 
participants completed a modified Positive and Negative Affect Schedule (PANAS; Watson 
et al. 1988) that we expanded to include three different words within each target emotion 
(amusement/happiness/joy; dejection/sadness/unhappiness; anxiety/fear/nervousness.) Each 
emotion was rated on a nine-point scale from ‘none’ to ‘extreme’ and averaged into 
composite scores for happiness (α = .89), sadness (α = .86), and fear (α = .82), all of which 
demonstrated excellent internal consistency.
Results
Baseline Measures
There was no effect of group (GAD, GAD + UDD, controls) on HRV at baseline, F(2,143) = 
1.525, p = .219.
As expected, we observed a significant main effect of group (GAD, GAD + UDD, controls) 
on the BDI, F(2,136) = 63.74, p < .001 and PSWQ, F(2,146) = 58.29. BDI scores in the 
GAD + UDD group (M = 23.44, SD = 8.31) were significantly greater than in the GAD 
group (M = 15.27, SD = 8.51) or in the control group (M = 5.77, SD = 6.13), p ≤ .001. 
PSWQ scores did not differ between the GAD group (M = 62.88, SD = 10.75) and the GAD 
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+ UDD group (M = 63.62, SD = 9.67), p = 1.000, but were significantly lower in the control 
group (M = 40.15, SD = 15.14) than in either GAD or GAD + UDD groups, p < 001.
There was also a significant main effect of the three-level group on baseline ratings for the 
RVAS, F(2,141) = 10.60, and WVAS, F(2,141) = 13.75, p < .001. Ratings did not differ 
significantly between the GAD group (RVAS: M = 41.79, SD = 29.53, WVAS M = 43.93, 
SD = 29.33) compared to the GAD + UDD group (RVAS: M = 54.48, SD = 36.37, WVAS M 
= 54.00, SD = 32.29), p ≥ .182. Both groups’ ratings were higher than those in the control 
group (RVAS: M = 25.86, SD = 25.86, WVAS: M = 23.35, SD = 25.23), p ≤ .003.
Manipulation Check
We conducted a 2 (baseline versus fear, sad, or happy film clip) × 3 (group) ANOVA for 
each of the three composite emotions (fear, sadness, and happiness.) There were significant 
within-subjects effects of period for fear, F(1,161) = 79.43,  = .33, for sadness, F(1,159) = 
180.17,  = .53, and for happiness, F(1,159) = 50.28,  = .24, all p < .001, such that ratings 
for each target emotion were greater during the film clip compared to baseline. Table 2 
shows mean ratings and their standard deviations for the three emotions in each period by 
group.
Subjective Response to Emotion
We next examined effects of group on the target emotion at baseline and during the film clip 
in order assess potential differences in subjective emotion ratings between GAD, GAD + 
UDD, and control groups (Table 2).
Fear—There was a small though significant effect of group, F(1,161) = 15.12, p = .009, 
= .06. Pairwise comparisons showed that baseline fear ratings in the GAD group were higher 
than those in the control group, p = .001, but lower than those in the GAD + UDD group, p 
= .031. However, fear ratings during the fear clip were similar across groups, p’s ≥ .52.
Sadness—There was a significant effect of group on sad ratings during baseline and the 
sad clip, F(1,159) = 7.28, p = .001,  = .08, such that sadness ratings both at baseline and 
during the sad clip were significantly lower in both the GAD group, p ≤ .048, and the control 
group, p ≤ .013, compared to the GAD + UDD group. There was no significant difference in 
sadness between the GAD and control groups, p ≥ .621 in either period.
Happiness—There was no between-subjects effect of group on happiness, F(1,159) = 
1.51, p = .224,  = .02, and no differences in happiness between groups either at baseline or 
during the happy film clip.
Physiological Response to Emotion
To examine differences in phasic HRV response to emotion as a function of GAD or 
comorbid GAD + UDD, we conducted repeated-measures ANOVAs in each of the emotion 
elicitations (fear, sadness, or happiness). Descriptive statistics for HRV in each time period 
by group are shown in Table 3. Each model predicted HRV in the three time periods over the 
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experiment (baseline, film clip, and recovery) from the three-level group, controlling for age 
and medication. F statistics are reported with Greenhouse-Geisser correction where there 
was a significant violation of sphericity assumption (Mauchly’s test p < .05). Overall, there 
were significant between-subjects effects of age and use of tricyclic antidepressants, SSRI/
SNRIs, and benzodiazepines across the various emotional contexts in all three models (Table 
4).
Fear—We found no significant main effect of period, F(2,250) = .57, p = .57,  = .005, nor 
group, F(2,125) = 1.57, p = .213,  = .024 on HRV. However, there was an interaction 
between period and group, F(4,250) = 2.78,  = .043, p = .027, such that HRV did not differ 
between groups with the exception of during the film clip, where the GAD group showed 
significantly lower HRV (M = 1.38, SD = .22) compared to the control group (M = 1.47, SD 
= .27), p = .024. There was no change in HRV over time in the GAD group, unlike the 
control group who showed a significant increase from HRV to the fear video, p < .001. 
There was also a trend for this pattern of lower HRV in the GAD group (M = 1.38, SD = .
22) relative to the control group (M = 1.48, SD = .28) continuing in the recovery period, p 
= .086, where HRV in the control group remained elevated relative to their HRV at baseline, 
p < .001. There were no differences between the GAD + UDD group and either the control 
or GAD groups. HRV in each group over the three time periods is shown in Fig. 1a.
Sadness—We found no significant main effect of period, F(1.88,228.21) = 1.12, p = .329, 
 = .009, nor group, F(2,121) = 1.90, p = .154,  = .03 on HRV, though there was a just-
significant interaction between period and group, F(3.77,228.21) = 2.53,  = .04, p = .045. 
HRV did not differ significantly between groups at baseline nor during the film clip. During 
the recovery period, the GAD group showed lower HRV (M = 1.35, SD = .25) compared to 
the control group (M = 1.45, SD = .25), p = .017, as well as the GAD + UDD group (M = 
1.44, SD = .24) though only at the trend level, p = .071. Interestingly, HRV in both the GAD 
and GAD + UDD groups declined significantly (p’s ≤ .049) from the sad clip to the recovery 
period, while HRV in the control group showed no such change, remaining elevated relative 
to baseline, p < .001. HRV in each group over the three time periods is shown in Fig. 1b.
Happiness—Again, there were no significant main effects on HRV of either period, 
F(1.80,221.44) = 1.10, p = .334,  = .009, or group, F(2,123) = 1.38, p = .324,  = .018. 
However, unlike the negative emotion elicitations, there was no interaction effect, i.e., no 
differences between groups in any period, F(3.60,221.44) = 0.71, p = .574,  = .011. 
Despite this finding, we did observe that individuals in the control group showed a 
significant increase in HRV from baseline to the happy clip, p < .001, a difference which 
was maintained during the recovery period (recovery > baseline p = .014). Although the 
GAD also showed an increase in HRV from baseline to the clip, p = .024, their HRV during 
the recovery period did not differ significantly from either baseline or the happy clip. The 
GAD + UDD group showed no physiological response to the happy clip, as evidenced by no 
significant pairwise comparisons for HRV between the three periods, p ≥ .288. HRV in each 
group over the three time periods is shown in Fig. 1c.
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Discussion
The ability to adapt to our mutable environment is fundamental to health and well-being 
(e.g., Aldao et al. 2015; Friedman 2007; Gross and Jazaieri 2014; Shaffer et al. 2014). In 
order to explore potential differences in emotional responding in GAD as a function of UDD 
comorbidity, we presented film clips designed to elicit fear, sadness, and happiness to a large 
community sample of individuals with GAD, comorbid GAD + UDD, and or no disorder. In 
summary, we observed significant interaction period-by-group effects on HRV during our 
negative emotion elicitations (fear and sadness), though not the happy elicitation. Although 
there was no difference in HRV between groups at baseline, the GAD group displayed 
significantly lower HRV during the fear film clip and sadness recovery period compared to 
the control group, while there was no significant difference between the comorbid GAD + 
UDD group compared to either the GAD group or controls at any timepoint. There were no 
group differences for happiness. Further, when we compared differences among timepoints 
within each group, we noticed a pattern of varying phasic responses. In response to all three 
emotions, controls’ HRV increased from baseline to the emotion film clip. Controls’ HRV 
also remained elevated relative to baseline during the recovery periods for fear and sadness. 
HRV in the GAD group also increased from baseline to film clip (in response to sadness and 
happiness only); however, individuals with GAD were unable to sustain these increases in 
HRV during the recovery period. Finally, the GAD + UDD group showed little phasic 
response to emotion apart from a transient increase in response to sadness; however, HRV 
did not differ significantly from either the GAD-only or control groups at any timepoint in 
the experiment.
These patterns of physiological responding among the three groups are particularly 
interesting in light of our findings with the subjective emotion ratings. Though we found 
significant effects of group for fear and sadness ratings, these differences appeared to be 
driven primarily by group differences at baseline (fear) or baseline and the clip (sadness). 
For both of these emotions, the comorbid group endorsed higher levels of negative affect 
relative to both GAD and control groups. At baseline, the GAD group endorsed higher levels 
of fear (but not sadness) compared to the control group. There were no differences between 
groups in happiness ratings at baseline or during the happy clip. These results might suggest 
that pre-existing (i.e., unrelated to the elicitation stimuli) negative affect in individuals in the 
GAD + UDD group may have had a dampening effect on their capacity for responding 
physiologically to the film clips, in line with the literature showing that depressed 
individuals are less sensitive to varying emotional contexts (e.g., Bylsma et al. 2008; 
Rottenberg et al. 2005b). It is also notable that, for the control group, HRV was augmented 
during the film clips and sustained in the recovery period. In contrast, individuals with GAD 
alone showed no phasic change in HRV (fear), or showed a transient increase in HRV, which 
ultimately fell back to baseline during the recovery period (sadness; happiness). In GAD, 
physiological inflexibility is thought to reflect a defensive and disorganized response style 
associated with reliance on avoidance and worry as means to manage intensely-felt emotions 
(e.g., Aldao and Mennin 2012; Llera and Newman 2010; Movius and Allen 2005; Thayer et 
al. 1996). Although not pathological in and of itself, greater affective intensity may lead 
individuals with GAD to adopt a rigid and defensive stance in efforts to cope with emotions 
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that feel overwhelming or threatening (e.g., Mennin and Fresco 2014). Further, non-
diagnosed individuals with high levels of difficulties in regulating emotions show a pattern 
of HRV response similar to that typically found in GAD: in a recent study, although HRV in 
both low- and high-difficulties groups decreased in response to negative emotion, the high-
difficulties group showed a prolonged decrease that persisted beyond the elicitation into the 
recovery period (Berna et al. 2014). Decreased HRV has also been linked to facets of 
emotion regulation deficits relevant to GAD—namely lack of emotional clarity and lower 
inhibitory control when experiencing negative emotions—even after controlling for anxiety 
and other covariates, supporting the link between physiological flexibility and adaptive 
response to emotion (Appelhans and Luecken 2006; Williams et al. 2015).
Greater psychological health is generally associated with a quadratic pattern representing 
rapid vagal withdrawal and recovery in response to a stressor. Here we observed an opposite 
response, where the film clips were associated with HRV augmentation rather than 
withdrawal. Although the patterns of HRV response to emotion observed in our sample may 
seem paradoxical, HRV was lowest during baseline for all groups. This may have resulted 
from anticipatory stress as participants sat quietly waiting for the experiment to begin in 
earnest. People often prefer doing something, including self-administering electric shocks, to 
being alone with their thoughts for as little as 6 min (Wilson et al. 2014). Further, higher 
HRV has been proposed to index increased self-regulatory effort or the ability to sustain 
attention and engage with stimuli in the environment (e.g., Porges et al. 1994; Segerstrom 
and Nes 2007), so we might interpret the prolonged increase in HRV in the control group as 
indicative of greater ability to self-regulate or to sustain attention compared to the GAD and 
GAD + UDD groups. Although speculative in absence of state worry measures during the 
film clips and recovery periods, it may be that the periods in which HRV was lower in the 
GAD group were those periods which led to greater worry. This could be either due to 
efforts in the recovery period to avoid emotions aroused by the film clips—or simply due to 
the anticipatory or ambiguous nature of the portions of the experiment that required 
participants to simply sit and wait for the next stimulus to occur. The lack of HRV 
augmentation in response to the film clips (other than sadness) in the GAD + UDD group 
might reflect blunted reactivity (e.g., Bylsma et al. 2008), deficits in motivated attention that 
are typically more specific to depression (e.g., Chantiluke et al. 2012), or simply greater 
severity in the comorbid group. Though GAD and GAD + UDD groups did not differ on our 
measures of worry symptoms (PSWQ) or state worry and rumination (WVAS/RVAS), the 
GAD + UDD group reported greater overall subjective negative affect, as well as higher 
levels of depressive symptoms (BDI) compared to both GAD-only and control groups. 
However, any conclusions regarding differences between the comorbid and non-comorbid 
groups should be interpreted with caution, given that we did not find any significant 
differences when comparing HRV in the GAD + UDD group to the other two groups.
Our results are qualified by a number of limitations, most notably the lack of a fourth, UDD-
only group, which would have allowed us to assess whether observed effects were unique to 
depression in the presence of generalized anxiety, or a feature of UDDs themselves. Studies 
have shown an inverse association between depression severity and tonic HRV (see Kemp et 
al. 2010, for a meta-analysis), and HRV has been suggested to be an indicator of treatment 
response (e.g., Balogh et al. 1993; Chambers and Allen 2002) or as a protective factor 
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against future depressive episodes under certain conditions (e.g., Hopp et al. 2013). Yet 
others have failed to find these relationships (e.g., Rottenberg 2007; Royster et al. 2012). 
Heterogeneous samples and methodology may have been one source of such contradictory 
findings (Rottenberg 2007; van Zyl et al. 2008). The DSM-5 currently categorizes recurrent 
MDD and dysthymia under the umbrella of ‘persistent depressive disorder’ in absence of 
meaningful evidence for their differentiation (American Psychiatric Association 2013). 
Previous studies have also combined MDD and dysthymia (Aldao et al. 2010; Liverant et al. 
2008). However, a notable limitation is that there have been few if any studies directly 
comparing HRV in MDD and dysthymia. Future investigations should seek to better 
characterize psychophysiological differences (or lack thereof) between individuals with 
MDD and dysthymia, given the changes to these diagnoses in the DSM-5. To test whether 
there were meaningful differences between the two diagnoses, we ran our HRV analyses in 
only in the subsample of GAD + UDD individuals, using specific UDD (MDD versus 
dysthymia) as a between-subjects factor. We observed no significant effects of having a 
comorbid dysthymia versus comorbid MDD diagnosis (p’s = .164–.675), nor any diagnosis 
× period interactions (p’s = .266–.648). However, our sample of 22 individuals with MDD 
and 14 individuals with dysthymia may have been underpowered to detect differences. 
Indeed, the control group in the present study was substantially larger than either GAD or 
GAD + UDD groups, itself an additional limitation. The sample used in this study were 
recruited as part of a larger study examining multiple emotion-related phenomena in mood 
and anxiety disorders, and the control group was used for multiple purposes within this 
larger study. In addition, we elected to drop a number of individuals from the diagnosed 
group who had characteristics that made them unsuitable for the present investigation. These 
included primary diagnosis of another Axis-I disorder (e.g., social anxiety, panic disorder), 
current substance abuse or dependence, or a depression diagnosis accompanied by the 
specifier “in full remission” or “in partial remission” that was reflected in a BDI score in the 
non-depressed range. These decisions contributed to the size discrepancy between the 
control group and the diagnosed groups. Related to this, another limitation is that lifetime 
UDD diagnoses were not assessed; therefore it is possible that individuals in the GAD or 
control groups may have previously had a depressive episode.
Future investigations should employ sufficiently large samples to explore variation within 
the UDD diagnosis and whether such variations differentially impact responses to emotion. 
For example, we know little about how depression-as-acute but time limited condition 
differs from depression-as-chronic mental illness (Monroe and Harkness 2011). Individuals 
who experience only a single life-time episode of depression have shown comparable 
emotional startle blink modulation to never-depressed controls, in contrast to individuals 
with chronic or recurrent forms of depression (Vaidyanathan et al. 2014). Similarly, 
melancholic and atypical subtypes of depression have been associated with distinctive 
patterns of physiological reactivity and dysregulation (e.g., Fotiou et al. 2003; Penninx et al. 
2013). Melancholia has been shown to feature an overactive stress response indexed by 
higher heart rate, lower HRV, and elevated serum cortisol, whereas metabolic and 
inflammatory dysregulation may be more specific to atypical depression (Kemp et al. 2014b; 
Penninx et al. 2013).
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In order to obtain a more complete understanding of how UDD impacts emotional 
experience in GAD, it likely will be necessary to measure different aspects of physiological 
activity in addition to HRV. For example, Fisher et al. (2010) found increased sympathetic 
activity at baseline moderated self-reported physiological arousal in participants with GAD 
only, whereas there was no relationship between subjective and physiological arousal in 
comorbid GAD. Further, greater anhedonia and motivational deficits in depression were 
found to be associated with reduced effort-related sympathetic activity, but were unrelated to 
HRV (Silvia et al. 2014). SNS measures may be more relevant to ANS dysregulation in 
UDD than HRV: in a recent study, sympathetic vasomotor tone was found to more strongly 
predict depressive symptoms than either HRV or blood pressure alone (Sanchez-Gonzalez et 
al. 2013). ANS dysregulation in GAD has been widely ascribed to the inhibitory effect of 
chronic worry on specifically parasympathetic flexibility (e.g., Lyonfields et al. 1995; 
Thayer et al. 1996). Yet the relationship between the SNS and PNS is not necessarily 
antagonistic (Cacioppo et al. 2007). Unfortunately, the present study did not include a 
reliable measure of sympathetic nervous system (SNS) activity. Although the CMetX 
program (Allen et al. 2007) does generate a sympathetic metric, this more accurately indexes 
shift in autonomic activity (from PNS-dominant to SNS-dominant) rather than degree, as 
other HRV metrics do, therefore we elected not to include this metric in our present 
investigation (Toichi et al. 1997). However, future studies should employ reliable measures 
of sympathetically-mediated cardiovascular activity such as pre-ejection period (i.e., 
impedance cardiography).
Future studies should also use emotion elicitation procedures that are sufficiently personally 
relevant and engaging in order to invoke stronger and more complex motivational states 
(Aldao 2013; Mennin and Fresco 2015). We observed that in general, the film clips did not 
elicit ratings commensurate with intense subjective emotions. All three groups showed only 
minor changes in subjective emotion in response to the film clips (Table 2). This may 
contribute to the small effect sizes associated with the observed changes in HRV and is 
congruent with the notion that the film clips generally did not elicit a strong emotional 
response in either subjective or physiological domains. Passively-viewed stimuli may suffer 
from a lack of personal or motivational relevance, resulting in a less intense emotional 
experience (Aldao 2013). It is also possible that the three emotions used here are limited in 
their relevance to GAD psychopathology, in which internally-generated images and thoughts 
(i.e., worries) may be more evocative than external stimuli (Mennin and Fresco 2015). 
Therefore, inducing threat or worry states might have been more effective in producing 
physiological changes comparable to those found in previous studies. Many of these studies 
involved worry or relaxation inductions—and worry and relaxation have been shown to 
increase anxiety in GAD (e.g., Heide and Borkovec 1984; Hofmann et al. 2010).
Despite the limitations described above, and although the effects of the film clips on 
subjective and physiological responses were small, the present study has several strengths, 
including a large (relative to many investigations of HRV in affective disorders) clinically 
diagnosed community sample. Given the centrality of emotion to GAD and UDD 
psychopathology, it is important to understand how affective processes such as generation 
and regulation are functionally related, as well as how factors such as comorbidity may 
moderate these relationships (e.g., Mennin et al. 2008; Mennin and Fresco 2015). The 
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present findings supplement the growing literature showing that GAD is associated with 
unique emotional and regulatory deficits that differ from deficits found in comorbid GAD + 
UDD (or UDD alone). Previous studies found patterns of compensatory neural activity in 
MDD during emotional conflict adaptation, versus impaired conflict adaptation in GAD, 
blunted emotion-modulated startle-blink in anxiety with comorbid UDD versus anxiety 
alone, and increased error-related brain activity in GAD versus GAD with comorbid MDD 
(e.g., Etkin and Schatzberg 2011; Taylor-Clift et al. 2011; Weinberg et al. 2012). These 
underscore the need to explore how shared characteristics such as negative affectivity might 
have different functions depending on clinical presentation. For example, GAD typically 
onsets earlier than UDD in comorbid presentations, so it may be that over time, heightened 
emotionality could ultimately give way to depressive symptoms such as anhedonia, flattened 
affect, and motivational deficits (e.g., Kessler et al. 1996; Mennin et al. 2008).
Although these findings results should be regarded as preliminary pending independent 
replication with a UDD-only group and a stronger emotion elicitation procedure, the lack of 
baseline differences in HRV here, in contrast to some previous work (e.g., Chang et al. 
2013), supports previous findings that suggest that examining change across various contexts 
(e.g., Hofmann et al. 2010) should better allow dysregulated processes that may not be 
evident at the tonic level to emerge. For instance, the GAD + UDD group reported elevated 
depressive symptoms and negative affect at the time of the experiment, which may suggest 
that their observed lack of physiological response to the film clips might be more related to 
broader deficits in emotion-related phenomena (e.g., amotivation, anhedonia, and emotion 
context insensitivity) which can limit individuals from fully engaging with their 
environment. Indeed, in a previous investigation, we found that greater dispositional positive 
affect, greater emotional intensity, and approach motivation distinguished GAD from UDD 
(Aldao et al. 2010). However, unlike controls, individuals in the GAD group did not sustain 
the increases in HRV that we observed between baseline, and happiness and sadness clips. 
This could also indicate efforts to avoid attending to emotional stimuli (though does not 
fully explain the lack of HRV response to the fear clip.) Although any conclusions based on 
group differences remain speculative at present, given the lack of significant differences in 
HRV between the GAD-only and comorbid group at any timepoint (and between the 
comorbid group and controls); however, we hope that the suggestions raised by these 
findings will guide subsequent investigations to consider comorbid UDD as a potentially 
important moderator of emotions at a functional level in GAD, even as these disorders share 
a number of common features.
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Fig. 1. 
a HRV during Baseline, Fear, and Recovery by Group. b HRV during Baseline, Sadness, and 
Recovery by Group. c HRV during Baseline, Happiness, and Recovery by Group. Note age 
and medications appear as covariates in the model
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Table 1
Sample characteristics by diagnostic group
Group
CTL GAD GAD + UDD
Demographics % (n)
 Male 40.5 (30) 30.6 (15) 35.3 (12)
 Female 59.5 (44) 69.4 (34) 64.7 (22)
 African-American/black 5.3 (4) 5.2 (3) 11.9 (5)
 Asian 7.9 (6) 8.6 (5) 16.7 (7)
 Caucasian/white 44.7 (34) 46.6 (27) 38.1 (16)
 Hispanic 5.3 (4) – 7.1 (3)
 Native American – 1 (1.7) –
 Other 3.9 (3) 5.2 (3) –
 (missing or not provided) 32.9 (25) 32.8 (19) 26.2 (11)
 Age M (SD) 26.56 (9.07) 28.44 (9.04) 30.75 (7.75)
Secondary diagnoses (n)
 Attention-deficit disorder – 1 –
 Eating disorder NOS – 3 1
 Obsessive–compulsive disorder – 2 2
 Panic disorder – 3 5
 Post-traumatic stress disorder – – 3
 Social anxiety disorder – 11 11
 Specific phobia – 12 11
Medication use (n)
 SSRI/SNRIs 3 5 4
 Benzodiazepines – 1 1
 Tricyclic antidepressants 1a – –
 Hormonal birth control 14 13 4
 Antihistamines and allergy 1 2 –
 Other (e.g. thyroid, asthma medication) 5 7 3
Data regarding the racial/ethnic makeup of the Kent sample was not available, so information reported (apart from the ‘missing or not provided’ 
category) is based on the n = 144 subsample from Yale. NOS = Not Otherwise Specified
aAmitriptyline is also used for non-psychiatric purposes (e.g., insomnia, pain, migraine treatment) and results of our HRV analyses did not differ 
after excluding this individual
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Table 2
Emotion ratings in each period (means and standard deviations)
Period Group M (SD)
Control GAD GAD + UDD
Baseline
 Fear 0.69 (0.97) 1.42 (1.17) 1.92 (1.50)
 Happy 1.91 (1.53) 1.74 (1.14) 1.53 (1.27)
 Sad 0.33 (0.78) 0.42 (0.76) 1.12 (1.71)
Fear clip
 Fear 2.64 (2.08) 2.85 (2.00) 2.97 (2.05)
 Happy 1.06 (1.21) 0.92 (1.20) 0.94 (1.25)
 Sad 0.46 (0.90) 0.44 (1.02) 1.42 (1.90)
Sad clip
 Fear 1.21 (1.32) 1.53 (2.04) 2.32 (1.81)
 Happy 1.53 (1.48) 1.20 (1.39) 0.90 (1.05)
 Sad 2.15 (1.60) 2.32 (1.76) 3.06 (1.77)
Happy clip
 Fear 0.76 (1.31) 1.07 (1.55) 1.77 (1.57)
 Happy 3.03 (1.71) 2.70 (1.70) 2.41 (1.35)
 Sad 0.37 (0.98) 0.70 (1.54) 1.29 (1.46)
Emotions were rated on a 10-point scale, where 0 = “none” and 9 = “extreme”
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Table 3
HRV in each time period by group (means and standard deviations)
Period M (SD) Group
Controls GAD GAD + UDD
Baseline 1.39 (0.28) 1.35 (0.24) 1.41 (0.22)
Fear clip 1.47 (0.27) 1.38 (0.22) 1.45 (0.20)
Fear recovery 1.46 (0.28) 1.38 (0.22) 1.43 (0.25)
Sad clip 1.48 (0.27) 1.41 (0.23) 1.47 (0.22)
Sad recovery 1.45 (0.25) 1.35 (0.25) 1.44 (0.24)
Happy clip 1.46 (0.29) 1.40 (0.24) 1.43 (0.24)
Happy recovery 1.43 (0.25) 1.39 (0.24) 1.43 (0.21)
Table shows the log-transformed MSD
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Table 4
Between-subjects effects of age and medication type on HRV
Fear F(1,125) p ηp
2
Age* 5.77 .018 .044
Tricyclic antidepressants** 9.06 .003 .068
SSRI/SNRIs* 3.98 .048 .031
Benzodiazepines* 7.98 .006 .060
Hormonal birth control 1.07 .302 .009
Antihistamines/allergy 0.09 .770 .001
Other (misc.) 0.39 .536 .003
Sadness F(1,123) p ηp
2
Age* 4.88 .029 .039
Tricyclic antidepressants* 5.65 .019 .045
SSRI/SNRIs* 6.09 .015 .048
Benzodiazepines* 6.79 .010 .053
Hormonal birth control 1.28 .261 .010
Antihistamines/allergy 0.93 .337 .008
Other (misc.) 0.78 .378 .006
Happiness F(1,121) p ηp
2
Age** 11.18 .001 .083
Tricyclic antidepressants* 6.78 .010 .052
SSRI/SNRIs* 6.38 .013 .049
Benzodiazepines* 5.78 .018 .045
Hormonal birth control 0.61 .437 .005
Antihistamines/allergy 1.15 .285 .009
Other (misc.) 0.27 .603 .002
‘Other (misc.)’ category includes other medications such as thyroid or asthma medications
*p < .05;
**p < .005
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